International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

Topics of interest for this program cover a broad range of infectious diseases research topics, including, but not limited to: tuberculosis, malaria, HIV/AIDS, parasitic diseases, vectors and vector-borne diseases, drug resistance (antimicrobial and/or insecticide), zoonoses with public health consequences, and other emerging and re-emerging infectious diseases that are of public health significance. Development of basic, immunological, microbiological, biostatistical, bioinformatics, genomics, epidemiological, data management, and clinical research capacity is encouraged.

Studies may be proposed on any aspect of infectious disease research (except clinical trials), including but not limited to: basic biological studies of pathogens and vectors; the epidemiology, natural history, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases; identification of resistance mechanisms and patterns; characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies; studies focused on the effects of climate change on the incidence, prevalence and severity of infectious diseases.

Note: HIV/AIDS studies must address NIAID priorities as described:

Collaborative projects involving investigators and institutions from international sites and the U.S. are encouraged; however, a U.S. partner is not required. Collaborative projects involving institutions in -low and -lower-middle economy countries are particularly encouraged. Applicants are encouraged to establish multi-institutional collaborations and to include activities that involve the transfer of technologies and research methods, sharing of core resources including the administration of research grant programs, and expansion of linkages to other sites via attendance at national and international meetings and other methods of communication. NIH supports several international research programs on infectious diseases, including HIV/AIDS. This International Research in Infectious Diseases (IRID) Program is intended to complement these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. This may include sites where NIH or NIAID already has significant investment in research and/or infrastructure. However, previous NIH funding is not a requirement.


Eligible Organizations

  • Non-domestic (non-U.S.) Entities (Foreign Institutions)
  • Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies) by World Bank Classification at the time of application submission. Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply.

Foreign Institutions

  • Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
  • Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
  • Foreign components, as defined in the NIH Grants Policy Statementare allowed. 

Eligible Individuals (Program Director/Principal Investigator)

  • Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.
  • PDs/PIs must have a primary appointment at an institution/organization in an eligible country. Investigators who currently serve or have served as PDs/PIs on R01-equivalent grants (other than an expiring/current IRID) or contracts funded by NIH are not eligible to apply.
  • For institutions/organizations proposing multiple PDs/PIs, all PDs/PIs must have primary appointment at an institution/organization in an eligible country.

Since Canada is classified as a high-income economy, SFU researchers can apply only as sub-recipients.

All Senior/Key Personnel must have an eRA Commons account. If you don't have an eRA Commons ID, please contact as soon as possible. 


NIAID intends to commit US$1,360,000 in FY 2024 to fund 7-8 awards. Application budgets should not exceed US$125,000 in direct costs per year, and should reflect the actual needs of the project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.

No more than 20% of the budget (direct costs) in any year may be subcontracted to an institution in a high-income economy country (World Bank Classification). All subcontracts combined to such high-income economy countries should account for no more than 20% of the budget (direct costs). Subcontracts to eligible foreign institutions are not subject to this cap. 


Application Due Dates Review and Award Cycles
New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
August 02, 2023 August 02, 2023 August 02, 2023 November 2023 January 2024 March 2024
August 02, 2024 August 02, 2024 August 02, 2024 November 2024 January 2025 March 2025
August 01, 2025 August 01, 2025 August 01, 2025 November 2025 January 2026 March 2026

All applications are due by 5:00 PM local time of applicant organization.

For more information, please visit the website

SFU Instructions 

SFU Signature Sheet, scope of work, budget and budget justification due to at least 3 business days prior to the deadline. Please include 8% of modified total direct costs as indirect costs in your budget. If you require any institutional documentation for this submission, please contact as soon as possible. 


Upcoming Deadlines